This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Evaluation
  • Claim Credit
Improving the Safety of Neuromuscular Blockade in Surgical Patients Through Monitoring and Improved Communication

Improving the Safety of Neuromuscular Blockade in Surgical Patients Through Monitoring and Improved Communication

Format

Newsletter

Time to Complete

30 minutes

Released

March 29, 2019

Expires

March 31, 2020
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 CreditTM

Pharmacy Credits

Pharmacists may earn 0.50 CPE Credit (0.05 CEU) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website, and free registration on the ASHP website is required). Your certificate will save on ASHP.org and will not be included in your myCME CME History.

Accredited Provider



This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).

Commercial Supporter

Supported by an educational grant from Merck.

Program Description

Part 1 of this two-part activity focuses on the need for monitoring neuromuscular blockade and reversal in surgical patients and the different types of available monitoring equipment. Part 2 addresses barriers to monitoring and the need for improved communication among the perioperative team at transitions of care. A framework to guide successful implementation of quality improvement interventions is discussed.

Intended Audience

This activity was planned to meet the educational needs of pharmacists, physicians, physician assistants, and nurse practitioners involved in anesthesia and perioperative care within hospitals and health systems.

Educational Objectives

At the conclusion of this knowledge-based educational activity, participants should be able to:

  • Compare the advantages and disadvantages of qualitative and quantitative electronic devices for monitoring neuromuscular blockade and reversal.
  • Develop an intervention plan for monitoring neuromuscular blockade and reversal in surgical patients that includes communication among the perioperative team at transitions of care.

Conflict Of Interest Disclosure Policy

In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships.

Faculty

Rachel C. Wolfe, PharmD, BCCCP
Clinical Pharmacy Specialist
Perioperative Services and Surgical Critical Care
Barnes-Jewish Hospital
St. Louis, Missouri

Dr. Wolfe discloses the following:
Advisor Board: Fresenius Kabi USA, LLC

Bernadette Henrichs, PhD, CRNA, CCRN
Director, Nurse Anesthesia Program
Barnes-Jewish College Goldfarb School of Nursing
Director, CRNA Education and Research
Washington University Department of Anesthesiology
St. Louis, Missouri

Dr. Henrichs discloses the following:
Speakers Bureau: Merck
Advisor Board: Fresenius Kabi USA, LLC

Satya Krishna Ramachandran, MD
Associate Professor of Anaesthesia
Harvard Medical School
Vice Chair of Quality, Safety, and Innovation
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Dr. Ramachandran discloses the following:
Advisor Board: Fresenius Kabi USA, LLC

Accredited Provider Disclosure

The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Instructions

In order to receive credit, participants must view the activity, including all polling questions, and complete the program evaluation. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

For information about the accreditation of this program, please contact elearning@ashp.org.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue